Á¦ ¸ñ    swifiPGftzDMGP
ÀÌ ¸§    Shayne ³¯ Â¥    2018/06/28 Á¶ ȸ    1


Sorry, you must have the wrong number atarax tablet usage Meanwhile, biopharma companies are increasingly challenged by scarce resources to conduct genomic biomarker analysis in-house. Following Dr. Crosby's talk, Dr. Sirosh Bokhari presents data from a recent study to validate data across multiple modalities for pipeline decision-making. The study was conducted to investigate the mechanisms of resistance to tyrosine kinase inhibition in non-small cell lung cancer cell lines with activating or resistance-conferring mutations.